Using high‐dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system
暂无分享,去创建一个
[1] M Alan Brookhart,et al. Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. , 2009, Journal of clinical epidemiology.
[2] Sebastian Schneeweiss,et al. Multivariate‐adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases , 2010, Pharmacoepidemiology and drug safety.
[3] J. Rassen,et al. Confounding Control in Healthcare Database Research: Challenges and Potential Approaches , 2010, Medical care.
[4] Paul Zador,et al. Variable selection and raking in propensity scoring. , 2007, Statistics in medicine.
[5] M. Maclure. The case-crossover design: a method for studying transient effects on the risk of acute events. , 1991, American journal of epidemiology.
[6] M Alan Brookhart,et al. Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. , 2009, Journal of clinical epidemiology.
[7] R. Makuch,et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.
[8] J. Myers,et al. Effects of adjusting for instrumental variables on bias and precision of effect estimates. , 2011, American journal of epidemiology.
[9] G. Shaw,et al. Maternal pesticide exposure from multiple sources and selected congenital anomalies. , 1999 .
[10] Sengwee Toh,et al. Confounding adjustment via a semi‐automated high‐dimensional propensity score algorithm: an application to electronic medical records , 2011, Pharmacoepidemiology and drug safety.
[11] Lise,et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.
[12] I. Bross. Spurious effects from an extraneous variable. , 1966, Journal of chronic diseases.
[13] Donald Rubin,et al. Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.
[14] Jeremy A Rassen,et al. Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics , 2010, Medical care.
[15] Sebastian Schneeweiss,et al. Instrumental variable methods in comparative safety and effectiveness research , 2010, Pharmacoepidemiology and drug safety.
[16] D. Rubin. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials , 2007, Statistics in medicine.
[17] C R Weinberg,et al. Toward a clearer definition of confounding. , 1993, American journal of epidemiology.
[18] J. Avorn,et al. High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data , 2009, Epidemiology.
[19] J. Pearl,et al. Causal diagrams for epidemiologic research. , 1999, Epidemiology.
[20] W. Ray,et al. Evaluating medication effects outside of clinical trials: new-user designs. , 2003, American journal of epidemiology.
[21] S. Schneeweiss,et al. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. , 2010, Archives of general psychiatry.
[22] J. Rassen,et al. Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses , 2012, Pharmacoepidemiology and drug safety.
[23] J. Pearl. Invited commentary: understanding bias amplification. , 2011, American journal of epidemiology.
[24] J. Avorn,et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. , 2010, Journal of the American Medical Association (JAMA).
[25] S. Greenland. Quantifying Biases in Causal Models: Classical Confounding vs Collider-Stratification Bias , 2003, Epidemiology.
[26] M Maclure,et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. , 2001, American journal of epidemiology.
[27] Sebastian Schneeweiss,et al. Comparative Safety of Antidepressant Agents for Children and Adolescents Regarding Suicidal Acts , 2010, Pediatrics.
[28] R J Glynn,et al. Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development , 2011, Clinical pharmacology and therapeutics.
[29] Judea Pearl,et al. On a Class of Bias-Amplifying Variables that Endanger Effect Estimates , 2010, UAI.
[30] J. Avorn,et al. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. , 2010, American journal of epidemiology.
[31] M Alan Brookhart,et al. Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. , 2011, American journal of epidemiology.
[32] Sebastian Schneeweiss,et al. Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome , 2009, Circulation.
[33] K. Huybrechts,et al. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes , 2011, Canadian Medical Association Journal.
[34] Sebastian Schneeweiss,et al. A basic study design for expedited safety signal evaluation based on electronic healthcare data , 2010, Pharmacoepidemiology and drug safety.
[35] Joshua D. Angrist,et al. Identification of Causal Effects Using Instrumental Variables , 1993 .
[36] R Day,et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.
[37] P. Mahalanobis. On the generalized distance in statistics , 1936 .